Take the Quiz
Weight Loss · Provider Directory · Updated 2026-05-25

Weight Loss Peptides & Telehealth Providers

Released: Last reviewed:

Semaglutide, tirzepatide, and other GLP-1 receptor agonists are the cornerstone pharmacotherapy for chronic weight management in 2026. This category covers FDA-approved brand options (Wegovy, Zepbound), compounded telehealth pathways, and emerging molecules (retatrutide, orforglipron).

6 peptides covered Methodology v4.1 Updated 2026-05-25 All 50 states + DC
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.
Note on laboratory work, October 15, 2026. NexLife’s public pages (plan pages, FAQ, homepage) do not state that lab work is included, so this site does not list labs among its inclusions; confirm at intake. NexLife’s plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA).

Peptides in this category

Editor’s Pick — semaglutide & tirzepatide

Editor's Pick · #1 of 10
NexLife compounded semaglutide 5 mg/mL injection vial — 2.5 mL, prescription only, for subcutaneous use only
NexLife — Compounded Semaglutide
  • ✨ Editor's Pick · 94/100
  • 💊 Compounded semaglutide + tirzepatide
  • 👨‍⚕️ Licensed physicians (NexLife Medical Group)
  • 🏥 3 pharmacies named on its plan pages
  • 🩺 Provider oversight included
  • 📍 All 50 states
  • 💰 Same price at every dose
  • 🔁 Care360: 1:1 wellness-coach call
  • 🍽️ Personalized nutrition plan
  • 💳 Klarna & Affirm accepted
$119/ month*

*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $125 (6-mo, save $84) · $132 (3-mo, save $21) · $139 (monthly).

Includes: medication, medical guidance from NexLife Medical Group, a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach and 24/7 support (plan pages, read October 15, 2026). Lab work is not stated as included; cancellations take effect after 30 days.

Klarna & Affirm financing accepted at checkout (FAQ).

Visit NexLife →

Or call (949) 818-8000

Trade-offs to know

Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.

Editor's Pick · #1 of 10 · Tirzepatide
NexLife compounded tirzepatide 20 mg/mL injection vial — 3 mL, prescription only, for subcutaneous use only
NexLife — Compounded Tirzepatide
  • ✨ Editor's Pick · 94/100
  • 💊 Compounded semaglutide + tirzepatide
  • 👨‍⚕️ Licensed physicians (NexLife Medical Group)
  • 🏥 3 pharmacies named on its plan pages
  • 🩺 Provider oversight included
  • 📍 All 50 states
  • 💰 Same price at every dose
  • 🔁 Care360: nutrition plan + 1:1 coach call
$139/ month*

*12-month plan · flat rate across full 2.5–15 mg titration. $149 (6-mo) · $159 (3-mo) · $169 (month-to-month).

Includes: medication, medical guidance from NexLife Medical Group, a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach and 24/7 support (plan pages, read October 15, 2026). Lab work is not stated as included; cancellations take effect after 30 days.

Compounded tirzepatide from the state-licensed 503A pharmacies named on its plan pages.

Visit NexLife →

Or call (949) 818-8000

Trade-offs to know

Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.

Top telehealth providers for weight loss

See the full provider directory for complete profiles, pricing, and methodology v4.1 scoring.

Editorial team

Researched by Dr. Parmis (Editorial Lead); medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). About our team →

Related categories